News and Announcements
Bulletproof Share Purchase Plan Over-Subscribed
- Published November 05, 2015 11:49AM UTC
- Publisher Wholesale Investor
- Categories Company Updates
4th November 2015, ASX Announcement
Bulletproof Group Limited (ASX: BPF) is pleased to announce that the offer to eligible shareholders to participate in a share purchase plan (SPP) announced on 16 September 2015, has been completed with strong demand resulting in applications for three times the expected take-up. The plan was announced with an offer price of $0.25 per share, the same price as the institutional placement that was used to fund the acquisition of Infoplex Pty Ltd. A waiver from the ASX was granted under listing rule 7.1 to allow an offer price at a 22.6% discount to the 5-day VWAP prior to the offer being announced.
The Company advises that applications will be scaled back equally by around 24% to arrive at a final total of $3.5m, some 2.3x the initially expected take-up.
To read the full announcement, please click here.
Company Updates
Capital Is Flowing – Just Not to Everyone: Inside Australia’s $1.8 Billion Q1 2026
Australia’s startup ecosystem opened 2026 with a number that demanded attention. In the first three months of the year, $1.8 billion was raised across 81 venture deals and 26 accelerator rounds. That makes Q1 2026 the strongest start to a year since the 2022 boom, up 63% on Q1 2025, and more than double the […]
The control layer for the electrified home
THE MARKET SHIFT Australian households have been pulled into a real-time energy market they never knowingly signed up for. Flat electricity tariffs are disappearing. In their place: dynamic, time-of-use pricing that changes depending on when power is consumed. Electricity is now cheapest when solar floods the grid in the middle of the day — and […]
500 Million Episodes, Limited Treatment: How Patrys is Bridging the Gap in an Underserved Market
In the clinical vocabulary of the Intensive Care Unit, there is perhaps no word that carries as much quiet dread as delirium. It is a “chemical storm” of the brain—an acute dysfunction where the delicate balance between calming and activating signals is scrambled. For the patient, it can be a waking nightmare of hallucinations and […]
Backed By Leading Investment Groups and Family Offices
